FDA gives thumbs down to MDMA for now, demanding further research
(By Will Stone for NPR) On Friday, drugmaker Lykos Therapeutics received word from the Food and Drug Administration that the
Read More
Part D/Prescription Drugs
Medicare Advantage in 2024: Premiums, Out-of-Pocket Limits, Supplemental Benefits, and Prior Authorization
(By Meredith Freed, Jeannie Fuglesten Biniek, Anthony Damico, and Tricia Neuman for The Kaiser Family Foundation Published: Aug 08, 2024)
Read MoreWeight loss drugs 1 factor behind ACA premium increases: 3 things to know
(By Rylee Wilson for Becker’s Hospital Review) Premiums for plans on the ACA marketplace will rise 7% on average in
Read MoreWhat to Know About Medicare Part D Premiums
(By Juliette Cubanski and Tricia Neuman for The Kaiser Family Foundation Published: Aug 01, 2024) The Inflation Reduction Act of
Read MoreMark Cuban’s big warning for employers
(By Jakob Emerson for Becker’s Hospital Review) Mark Cuban is issuing a big warning to self-insured employers: If your company
Read MoreCan a lobbying push led by veterans help MDMA get approved for PTSD treatment?
(By Will Stone for NPR) Working in the music industry, Rogers Masson traveled in plenty of circles where ecstasy made
Read MoreThe Landscape of Medicare and Medicaid Coverage Arrangements for Dual-Eligible Individuals Across States
(By Maria T. Peña, Maiss Mohamed, Jeannie Fuglesten Biniek, Alice Burns, Juliette Cubanski, and Tricia Neuman for The Kaiser Family
Read MoreMedicare negotiations for lower drug prices near the finish line
(By Sydney Lupkin for NPR) One of the first things President Biden touted in his announcement that he was bowing
Read MorePayment plan for drugs in 2025
One of the many changes the Inflation Reduction Act (IRA) changed is how Medicare recipients can pay for prescription drugs.
Read MorePay attention during the Open Enrollment Period
Although Medicare Open Enrollment is a few months away, it is not too early to learn about changes that may
Read More